(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CANCERTAIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CANCERTAIN

ST13

US500000079299995

Class

44

Filing

79299995

Registration

6599597

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

07/05/2022

Trademark type

Word

Nice classes

44

Filing date

09/28/2020

Registration date

12/28/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/28/2021

Last transaction

12/28/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

STADELI, MARTA ANN

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CanCertain Limited
Clyz Labs Limited

Representatives

Michael J. Leonard Fox Rothschild LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical diagnostic and testing services; provision of medical information and consulting services relating to the use of medical diagnostic and imaging equipment; medical servicestreatment of human diseases and disorderscancer; medical consulting services in the field of cancer and the treatment and prevention of cancer; providing human medical diagnostic and prognostic testing services; providing information in the field of cancers provided online from a computer database; medical diagnosticmonitoring and reporting services; medical servicesanalysis of individual patient data for medical diagnostic and treatment purposes to aid physicians and oncologists in determining medical diagnostictherapeutic and prognostic objectives for patients; informationadvisory and consultancy services relating to the aforesaid services

Publications

History of USPTO decisions and trademark events.

22 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/05/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/13/2022

FIMP

FINAL DISPOSITION PROCESSED

06/13/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/28/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/28/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

11/19/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/12/2021

PUBO

PUBLISHED FOR OPPOSITION

10/12/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/22/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/08/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/08/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/08/2021

RFNT

REFUSAL PROCESSED BY IB

03/29/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/08/2021

RFRR

REFUSAL PROCESSED BY MPU

03/08/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/03/2021

CNRT

NON-FINAL ACTION WRITTEN

03/02/2021

DOCK

ASSIGNED TO EXAMINER

02/20/2021

MAFR

APPLICATION FILING RECEIPT MAILED

12/22/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/18/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/17/2020

Continuous trademark protection

Get notified about every new filing that threatens CANCERTAIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.